Craig-Hallum analyst Matt Hewitt initiated coverage of Clover Health (CLOV) with a Buy rating and $6 price target
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CLOV:
Education
About Us
Working with TipRanks
Follow Us
